Allatostatins (ASTs) are insect neuropeptides that inhibit juvenile hormone biosynthesis by the corpora allata. We have isolated a cDNA from the cockroach Diuloptera punctata that encodes a 41.5-kDa precursor polypeptide containing the AST family of peptides. Translation of the cDNA revealed a 370-amino acid pre-propeptide consisting of 13 AST-type peptides and appropriate processing sites for endoproteolytic cleavage and amidation. The 13 potential AST sequences are characterized by the C-terminal AST corestructure Phe-Gly-Leu-NH2, with only one exception. Separating the clustered ASTs in the precursor, three acidic spacer regions are found. Contained within the largest of these are two potentiafly related peptides that may also be processed. Southem blot analysis revealed the presence of a single copy of the
Juvenile hormones (JHs) are sesquiterpenoid molecules produced by the corpora allata (CA) that play a central role in the metamorphosis and reproduction of most insect species. The presence of JH is required for maintenance of larval characteristics, whereas its absence results in the transition from larva to adult. In the adult female of most species, JH is also required for oocyte development (1) .
JH biosynthesis is probably regulated, in part, by a family of brain-derived neuropeptide amides called allatostatins (ASTs), which inhibit JH production by the CA (2) . Seven ASTs ranging in size from 8 to 18 amino acids have been purified from the cockroach Diploptera punctata (3) (4) (5) . All share the common C-terminal sequence Tyr-Xaa-Phe-GlyLeu-NH2, which has been demonstrated in vitro to be the minimum sequence capable of inhibiting JH biosynthesis (6, 7) . The cAMP-independent signal-transduction mechanism(s) through which ASTs exert their effect on the JH biosynthetic pathway is unclear (8). However, membrane receptors for ASTs have recently been identified (9). ASTs have also been identified and purified from muscle tissue, suggesting that these molecules may have other roles apart from regulation of JH production (10).
To date, a limited number of insect neuropeptide genes have been characterized (11) (12) (13) (14) (15) , despite the potential for application to pest control and management (16, 17) . The recent characterization of several AST peptides from D. punctata has provided the opportunity for application of molecular approaches to isolate the gene responsible for production of these factors. Also, in the event that a family of small peptides might be coded for in the form of a single large precursor, as for the Drosophila Phe-Met-Arg-Phe-NH2 (FMRFamide) group (18) , gene characterization provides the The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. opportunity to quickly identify additional members of the peptide family. We report here the characterization of a cDNA from the cockroach D. punctata that encodes such a precursor for the AST family ofneuropeptides. t The deduced precursor contains at least 13 potential ASTs, including all seven of the peptides previously isolated. Hybridization was done at 65°C in 5x standard saline phosphate/EDTA (SSPE)/10x Denhardt's solution/0.5% SDS/denatured salmon sperm DNA at 250 ,ug/ml for 16 hr (19). The hybridization probe was a random-primed 32p-labeled segment of the AST gene corresponding to bases 76-658 (see Fig. 2 ). The first wash contained 2x SSPE/0.1% SDS and was done at 60°C, followed by two more washes in 0.5x SSPE/0.1% SDS also at 602C.
MATERIALS AND METHODS
In Situ Hybridization. Brains from day 5 matedD. punctata females were fixed in 4% (wt/vol) paraformaldehyde and then desheathed by submersion in a solution of collagenase (Sigma, type II, 1 mg/ml) for 15 min before hybridization as described (21) . The hybridization probe was the same AST gene segment described above labeled with digoxygenin (21).
RESULTS
PCR Using Degenerate Oligonucleotides. To isolate the coding sequence of an internal portion of the AST-encoding gene, oligonucleotides were designed to amplify between the ends of the largest AST peptide sequence, the octadecapeptide ASB2 (4) . The degenerate sequences are diagrammed in Fig. 1 (primers 1 and 2) , in relation to the amino acid sequence of the peptide. Each oligonucleotide carries a 5' extension that provides restriction recognition sequences for cloning the fragments produced.
PCR amplification was done by using as template a cDNA pool synthesized from RNA extracted from the brains of virgin female cockroaches. A product of 66 bp was isolated and cloned; a number of the resulting clones were then sequenced. A consensus sequence for the amplified region was derived from these and used to design a third oligonucleotide having only one degenerate position (primer 3 in Fig.  1 ), with sufficient specificity to allow 5'-end-specific PCR of the cDNA.
One-sided PCR was used to amplify the 5' end of the sequence because the cDNA target had first been ligated to a plasmid vector. The plasmid provides a known reference point beyond the cDNA terminus where opposing primers can anneal (22). Therefore, one-sided PCR was performed by using two nested primer pairs: primers 2 and 3 ( Fig. 1 ) in conjunction with two vector-based primers T3 and SK (Stratagene), respectively. In retrospect, our consensus primer (primer 3) was found to have three mismatches with the authentic gene sequence. However, annealing of the primer was sufficient to amplify a DNA fragment of =380 bp, which upon sequencing was found to encode the appropriate N terminus for the peptide. This sequence was then used to design further pairs of specific oligonucleotide primers, enabling a similar application of one-sided PCR to derive fragments containing the 3' portion of the gene.
The AST Gene Sequence. The sequence of the AST cDNA was derived by direct sequencing of PCR-amplified material on both strands. The entire sequence produced by this method is presented in Fig. 2 . A variant of this sequence was also found in the cDNA (data not shown), which diverges from that shown in Fig. 2 at nt 1669. The alternative species is slightly shorter (1900 bp) and differs only in the extreme 3' region, beyond nt 1669.
Analysis of the cDNA sequence reveals a single large open reading frame beginning at residue 96 and ending at residue 1206 (Fig. 2) , which encodes an apparent precursor polypeptide of 370 amino acids. This pre-pro-AST is predicted to be 41.5 kDa in size, beginning with a methionine codon at nt position 96, which is positioned in a suboptimal translational context (23). Several potential sites for cleavage of a signal sequence are found clustered between amino acids 24 and 28 (24). The remainder of the open reading frame predicts a complex set of at least 13 AST-type peptides, each of which is bounded by potential dibasic endoproteolytic cleavage sites and ends with a glycine, which is the signal for C-terminal amidation by peptidyl-glycine a-amidating monooxygenase (PAM) (25) (Fig. 3) . Seven of these potential peptides have previously been purified, providing evidence that these cleavage sites are used in vivo. The peptide sequences are displayed in Table 1 in the order in which they appear in the gene sequence and have been numbered accordingly. We believe this to be the most practical convention for future AST nomenclature.
All but one of the peptides includes the C-terminal amino acid sequence Phe-Gly-Leu, whereas 10 of the group are further alike in encoding tyrosine in the fifth position from the terminus ( Table 1 ). The last of these peptides, AST-13, is unique in having isoleucine as the C-terminal residue. The N-terminal regions of the predicted peptides are rather more variable, suggesting the likelihood that address sequences for individual targeting, function, or degradation rate may be located here.
An unusual feature ofthe organization ofthe AST peptides in the precursor is their tendency to be clustered in groups, separated by spacer regions of extremely high acidity in the protein sequence (Fig. 3) glycine as an amidation signal, but both do contain isoleucine as their C-terminal amino acid, in common with AST-13.
Searches of the GenBank and SwissProt data bases for homologous sequences using these two peptides produced no significant matches.
The predicted AST precursor terminates at a TAA stop codon at position 1206 (Fig. 2) . The untranslated nucleotide sequence that follows is extremely A + T rich and extends for >700 bp. Potential signals for polyadenylylation are located near the 3' end of this region.
Genomic DNA Analysis. Copy number ofthe AST-encoding gene was examined by Southern analysis of D. punctata genomic DNA. Fig. 4 (Fig. 2) . The Fig. 2 ). Genomic DNA samples were digested with various restriction enzymes (M, Mse I; H, Hpa H; E, EcoRI; S, Sal I; X, Xho I). DNA size markers (bases) are indicated at right. sequence errors, data were collected from both strands ofthe DNA, using independently amplified templates.
The occurrence of two products in PCR amplifications of the 3' end of the AST cDNA suggests that the AST mRNA might undergo alternative splicing. The affected region is contained entirely within the 3' untranslated sequence downstream of nt 1669 (Fig. 2) . Both of the possible 3' combinations are extremely A + T rich. Highly A + U-rich sequences in the 3' regions of some mRNAs have been shown to affect message stability (27). It is, therefore, tempting to speculate that important information regulating relative mRNA degradation rates resides in these different 3' arrangements of the AST mRNA.
The deduced sequence of the AST precursor contains all the appropriate signals for an exported protein capable of being processed into 13 amidated AST-type peptides. The peptide sequences confirm the structures of seven previously isolated ASTs and predict at least six new candidates. These potential ASTs are largely consistent with the basic structural-core motif for AST activity of Tyr-Xaa-Phe-Gly-Leu-NH2, with two notable exceptions. (i) In ASTs 10-12, phenylalanine is substituted for tyrosine in the fifth position from the C terminus; the consequences of this alteration on activity remain to be studied. (ii) The final peptide (AST-13) contains isoleucine in place ofleucine at the C terminus. This change may, in fact, have a relatively limited impact on the effectiveness of the peptide in inhibiting JH production. An analogous peptide variant of (with isoleucine at the C terminus) was reported by Pratt et al. (4) to inhibit JH production in CA from 10-day-old female D. punctata to a similar degree as the authentic product ending with leucine.
Curiously, both potential peptides located within the third acidic spacer region also have C-terminal isoleucine residues. However, neither of these peptides would be expected to be amidated. Previous studies using synthetic ASTs modeled on isolated peptides have found amidation an absolute requirement for significant JH inhibition (ref. 7 and S.S.T., unpublished work). Making use of anti-AST antibodies, ASTs have been identified in nerves serving other insect tissues, particularly those projecting to the pulsatile organ muscle in D. punctata (10). This result suggests that other functions for this family ofbioactive peptides will most probably be found. These two nonamidated AST candidates should prove useful in the search for such functions.
In D. punctata, retrograde filling of axons from the CA with nickel chloride (28) corporis cardiaci II. Destruction of either medial or lateral cell regions or the axons that extend from them (29) relieves the inhibition ofJH biosynthesis imposed on the CA of virgin females, thus suggesting that ASTs are produced from both cell types. Recently, the immunoreactivity ofthe D. punctata brain was described by using monoclonal antibody raised to . Lateral neurosecretory cells and associated nervi corporis cardiaci II are the major source of AST immunoreactivity extending to the CA. However, in agreement with our in situ hybridization observations, four medial cells are strongly immunopositive. These immunopositive medial cells terminate within the protocerebrum in areas where lateral cells form arborizations, rather than extending to the CA. Although AST mRNA expression was not evident in lateral cells ofthe brain by whole-mount in situ hybridization, preliminary studies using brain sections have indicated that cells within the lateral and tritocerebral regions also express AST mRNA at low levels compared with the four positive medial cells (unpublished work).
